IWA
BMRN icon

Inspirion Wealth Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Inspirion Wealth Advisors’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$57.8K Hold
1,000
– – 0.01% 186
2026
Q1 		$56.5K Buy
+1,000
New +$58.3K 0.01% 178
2025
Q1 		– Sell
-300
Closed -$20.4K – 162
2024
Q4 		$20.4K Sell
300
-400
-57% -$26.8K ﹤0.01% 153
2024
Q3 		$49.2K Buy
+700
New +$58.5K 0.01% 152
2024
Q2 		– Sell
-200
Closed -$17 – 150
2024
Q1 		$17 Sell
200
-39,800
-100% -$3.56M ﹤0.01% 151
2023
Q4 		$40 Buy
40,000
+39,800
+19,900% +$3.52M ﹤0.01% 140
2023
Q3 		$18 Buy
+200
New +$17.8K ﹤0.01% 137

Other funds holding BMRN

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
EIP
Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
CF
Covea Finance Paris, France $3.17B AUM 35.01% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return

Inspirion Wealth Advisors's BMRN Position: Q2 2026 in Review

Inspirion Wealth Advisors reduced its BioMarin Pharmaceuticals (BMRN) stake by 0.48% in Q2 2026, selling an estimated $2.46K and leaving 9,283 shares worth $537K. The position accounts for 0.06% of the portfolio, ranked #110.

Inspirion Wealth Advisors first reported a position in BMRN in Q1 2021 and has held it in 22 quarters since. The position peaked at $1.26M in Q4 2023. 140 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

  • Inspirion Wealth Advisors held 9,283 shares of BioMarin Pharmaceuticals worth $537K as of Q2 2026.
  • Inspirion Wealth Advisors sold 45 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $2.46K.
  • BioMarin Pharmaceuticals made up 0.06% of Inspirion Wealth Advisors's portfolio in Q2 2026, its #110 holding.
  • Inspirion Wealth Advisors first reported a position in BioMarin Pharmaceuticals in Q1 2021 and has held it in 22 quarters since.
  • Inspirion Wealth Advisors's BioMarin Pharmaceuticals position peaked at $1.26M in Q4 2023.
  • 140 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Inspirion Wealth Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.